Hostname: page-component-77f85d65b8-6c7dr Total loading time: 0 Render date: 2026-04-17T18:42:05.630Z Has data issue: false hasContentIssue false

Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes

Published online by Cambridge University Press:  06 April 2010

Fulvia Di Iulio
Affiliation:
Fondazione Santa Lucia, Istituto di Ricovero e Cura a Carettere Scientifico (IRCCS), Rome, Italy
Katie Palmer*
Affiliation:
Fondazione Santa Lucia, Istituto di Ricovero e Cura a Carettere Scientifico (IRCCS), Rome, Italy
Carlo Blundo
Affiliation:
Department of Neurology, San Camillo Hospital, Rome, Italy
Anna Rosa Casini
Affiliation:
Department of Neurological Science, San Giovanni Hospital, Rome, Italy
Walter Gianni
Affiliation:
Geriatric Unit, INRCA-IRCCS, Rome, Italy
Carlo Caltagirone
Affiliation:
Fondazione Santa Lucia, Istituto di Ricovero e Cura a Carettere Scientifico (IRCCS), Rome, Italy Department of Neuroscience, Tor Vergata University, Rome, Italy
Gianfranco Spalletta
Affiliation:
Fondazione Santa Lucia, Istituto di Ricovero e Cura a Carettere Scientifico (IRCCS), Rome, Italy Department of Neuroscience, Tor Vergata University, Rome, Italy
*
Correspondence should be addressed to: Katie Palmer, IRCCS Fondazione Santa Lucia, Via Ardeatina 306, 00179 Roma, Italy. Phone: +39 06 51501920; Fax: +39 06 51501575. Email: k.palmer@hsantalucia.it.
Get access

Abstract

Background: Neuropsychiatric disorders are common in cognitively impaired older persons, and associated with institutionalization and caregiver stress in Alzheimer's disease (AD). Few studies have compared the occurrence of both psychiatric disorders and neuropsychiatric symptoms in patients with AD and mild cognitive impairment (MCI) subtypes. We aimed to investigate the frequency of psychiatric disorders and neuropsychiatric symptoms in AD and MCI patients, compared to controls.

Methods: We included 245 outpatients of a memory clinic in Rome, Italy (119 AD; 68 multidomain-MCI; 58 amnestic-MCI) and 107 controls. Categorical disorders of depression and apathy were diagnosed with structured interviews. Symptoms were evaluated with the Neuropsychiatric Inventory (NPI). The odds ratios (OR) of patients having neuropsychiatric symptoms compared to controls were calculated with logistic regression, adjusted for sociodemographic and clinical variables.

Results: A large proportion of AD (49.6%) and multidomain-MCI (44.1%) patients had depression disorder. Apathy disorder was common in AD (51.3%) but less frequent in amnestic-MCI (6.9%) and multidomain-MCI (14.7%). AD patients were three times more likely to have depression disorders (OR = 3.0, CI = 1.1–7.6) or apathy (OR = 16.9, CI = 4.6–61.8) compared to amnestic-MCI, and seven times more likely to have apathy disorder than multidomain-MCI (OR = 7.5, CI = 3.0–19.2). After apathy and depression, the most prevalent neuropsychiatric symptoms in AD and MCI were anxiety, agitation, irritability, night-time behaviors, and appetite disturbances. There was an increasing prevalence of many neuropsychiatric symptoms with increasing severity of cognitive syndromes.

Conclusions: Clinicians should consider the relevance of neuropsychiatric disorders and symptoms in patients with cognitive disturbances, and incorporate a thorough psychiatric examination in the evaluation of patients.

Information

Type
Research Article
Copyright
Copyright © International Psychogeriatric Association 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable